| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| capecitabine irinotecan and bevacizumab | 1.97 | 0.7 | 9882 | 51 | 39 |
| capecitabine | 1.85 | 0.6 | 429 | 8 | 12 |
| irinotecan | 0.33 | 0.9 | 1209 | 71 | 10 |
| and | 0.25 | 0.6 | 4407 | 89 | 3 |
| bevacizumab | 0.78 | 0.7 | 7821 | 91 | 11 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| capecitabine irinotecan and bevacizumab | 1.93 | 0.2 | 4646 | 30 |
| capecitabine irinotecan bevacizumab | 0.15 | 0.2 | 1517 | 32 |
| capecitabine bevacizumab colorectal cancer | 1.97 | 0.8 | 1163 | 48 |
| tucatinib trastuzumab and capecitabine | 0.34 | 0.5 | 6661 | 28 |
| irinotecan bevacizumab glioblastoma protocol | 1.03 | 0.8 | 9707 | 44 |
| irinotecan and vectibix protocol | 0.16 | 0.9 | 7693 | 93 |
| capecitabine and pembrolizumab breast cancer | 0.07 | 0.5 | 2649 | 36 |
| capecitabine adjuvant breast cancer | 1.02 | 0.8 | 6667 | 1 |
| bevacizumab erlotinib renal cell carcinoma | 0.92 | 0.6 | 6118 | 42 |
| cabozantinib and nivolumab rcc | 1.66 | 0.9 | 4669 | 5 |
| capecitabine adjuvant colon cancer | 1.55 | 0.1 | 4743 | 96 |
| nice olaparib and bevacizumab | 1.58 | 0.4 | 8897 | 21 |
| bevacizumab irritant or vesicant | 0.42 | 0.1 | 5688 | 9 |
| capecitabine for breast cancer | 1.28 | 0.1 | 3461 | 91 |
| capecitabine for colon cancer | 0.62 | 0.7 | 3054 | 38 |
| capecitabine chemotherapy for colon cancer | 0.24 | 0.5 | 1355 | 33 |
